Xiao-Ping Jin

Prof. Xiao-Ping Jin


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XHXin-Wei He
Xin-Wei He
WLWei-Ling Li
Wei-Ling Li
CLCai Li
Cai Li
PLPeng Liu
Peng Liu
YSYu-Guang Shen
Yu-Guang Shen
XJXiao-Ping Jin
Xiao-Ping Jin
The aim of this study was to assess the expression patterns of serum galectin-1 (Gal-1), galectin-3 (Gal-3), galectin-9 (Gal-9), and galectin-3 binding protein (Gal-3BP) and their associations with stroke outcome in large artery atherosclerotic (LAA) stroke. The serum levels of Gal-1, Gal-3, Gal-9, and Gal-3BP were measured by ELISA in 130 patients with LAA stroke and 130 age- and sex-matched controls. Serum samples were collected from the patients on day 1, day 6, and in the 4th week after ischaemic stroke (IS). An unfavourable outcome was defined as a modified Rankin Scale score of >2 on day 90 after IS. Our results indicated that the Gal-3 and Gal-9 levels were higher in patients with LAA stroke than in controls. A higher Gal-3 level was independently associated with an unfavourable outcome both on day 1 and day 6 after IS. In addition, Gal-9 and Gal-1 levels were upregulated on day 6 and in the 4th week after IS, respectively. For Gal-3BP, no difference was detected between patients and controls and no predictive value was found in patients. In conclusion, these findings suggest that the serum levels of Gal-1, Gal-3, and Gal-9 may be associated with LAA stroke.

1 October 2016 in Atherosclerosis
Verified
Journal Article
Closed access
XHXin-Wei He
Xin-Wei He
EWEn Wang
En Wang
YBYu-Yan Bao
Yu-Yan Bao
FWFeng Wang
Feng Wang
MZMing Zhu
Ming Zhu
XJXiao-Ping Jin
Xiao-Ping Jin

1 March 2018 in Clinica Chimica Acta
Verified
Journal Article
Closed access
XHXin-Wei He
Xin-Wei He
SKShaofa Ke
Shaofa Ke
YBYu-Yan Bao
Yu-Yan Bao
WHWei-Jun Hong
Wei-Jun Hong
YSYu-Guang Shen
Yu-Guang Shen
XJXiao-Ping Jin
Xiao-Ping Jin

6 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XHXinwei He
Xinwei He
YBYuyan Bao
Yuyan Bao
YSYuguang Shen
Yuguang Shen
EWEn Wang
En Wang
WHWeijun Hong
Weijun Hong
XJXiao-Ping Jin
Xiao-Ping Jin
Increasing evidence supports the involvement of periostin in the pathophysiological processes of stroke and atherosclerosis. The aim of this study was to assess circulating periostin levels at different times after large-artery atherosclerotic (LAA) stroke and their association with stroke. Serum periostin levels were measured using enzyme-linked immunosorbent assay on day 1 in 162 patients with LAA stroke and in 108 age- and sex-matched controls, on day 6 after stroke in 134 patients, and during the 4th week after stroke in 46 of the 162 patients. Stroke severity was determined using the National Institutes of Health Stroke Scale (NIHSS), and the stroke volume was measured. Outcome at 3 months was measured using the modified Rankin Scale (mRS). Our results indicated that periostin levels increased significantly on day 6 after stroke, and this increasing trend persisted for at least 4 weeks after the event. In addition, the increase in periostin levels was positively correlated with the NIHSS scores and stroke volume, but not with the mRS scores after adjusting for the NIHSS scores. In conclusion, these findings suggest that the increase in serum periostin levels observed after stroke may be associated with the stroke severity in patients with LAA stroke.

4 February 2016 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
PDF file
XHXin-Wei He
Xin-Wei He
YSYu-Guang Shen
Yu-Guang Shen
MZMin Zhu
Min Zhu
XHXiao-Fei Hu
Xiao-Fei Hu
ZZZhou Zheng
Zhou Zheng
XJXiao-Ping Jin
Xiao-Ping Jin